Justin Walsh
Stock Analyst at JonesTrading
(4.67)
# 831
Out of 5,060 analysts
396
Total ratings
37.8%
Success rate
17.6%
Average return
Main Sectors:
Stocks Rated by Justin Walsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SPTX Seaport Therapeutics | Reiterated: Buy | $32 | $17.83 | +79.47% | 3 | Oct 12, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | $441 → $534 | $241.76 | +120.88% | 13 | Oct 1, 2026 | |
| RAPP Rapport Therapeutics | Reiterated: Buy | $50 | $27.57 | +81.36% | 22 | Sep 18, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $90 | $32.10 | +180.37% | 9 | Sep 15, 2026 | |
| RNXT RenovoRx | Reiterated: Buy | $8 | $1.14 | +601.75% | 6 | Aug 19, 2026 | |
| CLNN Clene | Reiterated: Buy | $30 | $3.10 | +867.74% | 15 | Aug 18, 2026 | |
| NMTC NeuroOne Medical Technologies | Reiterated: Buy | $8 | $0.9614 | +732.12% | 4 | Aug 18, 2026 | |
| SER Serina Therapeutics | Reiterated: Buy | $11 | $1.72 | +539.53% | 9 | Aug 18, 2026 | |
| ATNM Actinium Pharmaceuticals | Reiterated: Buy | $9 → $3 | $1.13 | +165.49% | 33 | Aug 14, 2026 | |
| CATX Perspective Therapeutics | Reiterated: Buy | $18 | $2.17 | +729.49% | 35 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $99.70 | - | 32 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $3.63 | +203.03% | 15 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.01 | - | 11 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.16 | - | 12 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $21.94 | +100.55% | 19 | Jun 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $24 | $0.1801 | +13,225.93% | 5 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $6.38 | +213.48% | 23 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $1.03 | +2,812.62% | 7 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $18.03 | - | 27 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $69.27 | n/a | 7 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.70 | n/a | 16 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.40 | $0.00 | n/a | 6 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $3.47 | n/a | 6 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $4 | $1.06 | n/a | 9 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.4071 | n/a | 12 | Jun 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $7.03 | n/a | 15 | May 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $20 | $27.28 | n/a | 2 | May 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.86 | n/a | 4 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $4.11 | n/a | 3 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $50.31 | n/a | 2 | Apr 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $0.000001 | n/a | 2 | Jan 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.09 | n/a | 2 | Nov 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.39 | n/a | 3 | Nov 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $12.90 | n/a | 5 | Nov 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $40 | $3.40 | n/a | 1 | Sep 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $1.17 | n/a | 1 | Feb 17, 2021 |
Seaport Therapeutics
Oct 12, 2026
Reiterated: Buy
Price Target: $32
Current: $17.83
Upside: +79.47%
Praxis Precision Medicines
Oct 1, 2026
Reiterated: Buy
Price Target: $441 → $534
Current: $241.76
Upside: +120.88%
Rapport Therapeutics
Sep 18, 2026
Reiterated: Buy
Price Target: $50
Current: $27.57
Upside: +81.36%
Definium Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: $90
Current: $32.10
Upside: +180.37%
RenovoRx
Aug 19, 2026
Reiterated: Buy
Price Target: $8
Current: $1.14
Upside: +601.75%
Clene
Aug 18, 2026
Reiterated: Buy
Price Target: $30
Current: $3.10
Upside: +867.74%
NeuroOne Medical Technologies
Aug 18, 2026
Reiterated: Buy
Price Target: $8
Current: $0.9614
Upside: +732.12%
Serina Therapeutics
Aug 18, 2026
Reiterated: Buy
Price Target: $11
Current: $1.72
Upside: +539.53%
Actinium Pharmaceuticals
Aug 14, 2026
Reiterated: Buy
Price Target: $9 → $3
Current: $1.13
Upside: +165.49%
Perspective Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $18
Current: $2.17
Upside: +729.49%
Aug 14, 2026
Reiterated: Hold
Price Target: n/a
Current: $99.70
Upside: -
Aug 10, 2026
Reiterated: Buy
Price Target: $11
Current: $3.63
Upside: +203.03%
Jul 31, 2026
Rated: Hold
Price Target: n/a
Current: $2.01
Upside: -
Jul 31, 2026
Rated: Hold
Price Target: n/a
Current: $2.16
Upside: -
Jun 26, 2026
Reiterated: Buy
Price Target: $44
Current: $21.94
Upside: +100.55%
May 18, 2026
Reiterated: Buy
Price Target: $60 → $24
Current: $0.1801
Upside: +13,225.93%
May 12, 2026
Reiterated: Buy
Price Target: $20
Current: $6.38
Upside: +213.48%
Mar 25, 2026
Reiterated: Buy
Price Target: $30
Current: $1.03
Upside: +2,812.62%
Jan 5, 2026
Rated: Hold
Price Target: n/a
Current: $18.03
Upside: -
May 14, 2025
Reiterated: Hold
Price Target: n/a
Current: $69.27
Upside: n/a
Mar 21, 2025
Rated: Hold
Price Target: n/a
Current: $1.70
Upside: n/a
Oct 30, 2024
Reiterated: Buy
Price Target: $0.40
Current: $0.00
Upside: n/a
Aug 8, 2024
Reiterated: Buy
Price Target: $20
Current: $3.47
Upside: n/a
Jun 4, 2024
Reiterated: Buy
Price Target: $8 → $4
Current: $1.06
Upside: n/a
Jun 6, 2022
Reiterated: Buy
Price Target: $10
Current: $0.4071
Upside: n/a
May 19, 2022
Reiterated: Buy
Price Target: $18
Current: $7.03
Upside: n/a
May 19, 2022
Reiterated: Buy
Price Target: $16 → $20
Current: $27.28
Upside: n/a
May 10, 2022
Reiterated: Buy
Price Target: $10
Current: $0.86
Upside: n/a
May 4, 2022
Reiterated: Buy
Price Target: $7 → $6
Current: $4.11
Upside: n/a
Apr 7, 2022
Reiterated: Buy
Price Target: $10
Current: $50.31
Upside: n/a
Jan 11, 2022
Upgraded: Buy
Price Target: $7
Current: $0.000001
Upside: n/a
Nov 26, 2021
Rated: Hold
Price Target: n/a
Current: $4.09
Upside: n/a
Nov 26, 2021
Rated: Hold
Price Target: n/a
Current: $6.39
Upside: n/a
Nov 17, 2021
Reiterated: Buy
Price Target: $30
Current: $12.90
Upside: n/a
Sep 2, 2021
Initiated Coverage: Buy
Price Target: $40
Current: $3.40
Upside: n/a
Feb 17, 2021
Initiated Coverage: Buy
Price Target: $4
Current: $1.17
Upside: n/a